Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

Q4 2024 Earnings Call Transcript February 12, 2025 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $-0.68699 ...

CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.

The company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.

Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...

Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.

We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...

A month before an expected jury trial was set to convene, Timothy M. Doll, 31, pleaded guilty Wednesday to murdering DeKalb ...

The 2025-26 budget presents a formidable challenge for Finance Minister Nirmala Sitharaman, as she grapples with pressing issues such as curbing inflation, boosting consumption, stimulating private ...

Randomized controlled trials are clinical trials in which at least two interventions — the test treatment and a control treatment — are simultaneously evaluated in two or more arms of the ...

Given that live TV streaming services cost a pretty penny, it's always worth looking for a way to test them without paying, and that's probably why you're looking for a Fubo free trial. While free ...

There's a free trial of this for one month, but just note, you can only get a free trial for the individual apps you haven't already used. So this won't work on Apple TV Plus if you've already used a ...